In a June 10 story about diabetes treatment research, The Associated Press reported erroneously that LY2605541 is a short-acting insulin. It is a long-acting insulin.
Also, Johnson & Johnson applied for U.S. approval to sell its experimental diabetes pill canagliflozin on May 31, not May 29.
Thomas Sowell - The 'Gun Control' Farce
Ruger Jumps Into Self Defense Ammo Market With Radical Bullet Design - Bearing Arms - Ammunition, ARX, Polycase, Ruger
Too bad to check: Aunt sues 12-year-old nephew for $127,000 for hugging her too exuberantly
Washington Post: The rich enjoy better breakfast sandwiches
Politico: Hillary Clinton is Screwed | RedState
- What Is Your U.S. Income Percentile Ranking?
Don't Take Your Guns to Town, Paul | Human Events